Gland Pharma Limited

Gland Pharma Limited

Performance

Today's Low Today's High
1,781.05 1,787.70
1,838.00 1831.70
52 Week Low 52 Week High
1,585.70 (23-Oct-2024) 1,590.00 (24-Oct-2024)
2,220.95 (06-Aug-2024) 2,220.95 (06-Aug-2024)

Open
1,822.25 1,820.00
Previous Close
1,813.25 1,814.10
Volume
0.88
Total Traded value
15.79 (₹ Lakhs)
Upper circuit
2,175.90 2,355.05
Lower circuit
1,450.60 1,570.05

Market Depth

Buy Order Quantity Sell Order Quantity
0
16

Bid PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--
Ask PriceQuantity
1,791.9516.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:16

Fundamentals

Market Cap: ₹294.74 Cr
PE Ratio (TTM): 26.77
PB Ratio: 3.22
Industry P/E:43.20
Debt to Equity:-
ROE:12.02
EPS (TTM):66.94
Book Value:509.34
Face Value: 1.00

Financials

Sep, 2023Jun, 2023Mar, 2023Dec, 2022Sep, 2022
Revenue1,010.67 Cr884.07 Cr785.42 Cr925.90 Cr1,048.31 Cr
Profit257.53 Cr187.58 Cr79.21 Cr227.54 Cr239.63 Cr
Expense704.72 Cr665.29 Cr655.99 Cr682.17 Cr791.46 Cr
Comprehensive income258.15 Cr187.02 Cr74.73 Cr228.28 Cr241.21 Cr
EPS15.6311.394.8113.8114.55
Gland Pharma Limited is a company based in Hyderabad, India that specializes in the development, manufacturing, and marketing of generic liquid parenteral products with a focus on injectables. The company offers a wide range of products under various therapeutic categories, including anti-infectives, anesthetics, anti-coagulants, anti-malarial, cardiology, gastro-intestinal, pain management, hormones, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood-related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. Some of its primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others.

In addition to its product offerings, Gland Pharma Limited also provides contract development services. The company primarily sells its products through a business-to-business model in the United States, Europe, Canada, Australia, India, and other international markets.

Established in 1978, Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Company nameListing dateIndustry NSE symbol BSE symbol
Gland Pharma Limited Nov, 2020 Nov, 2020 Pharmaceuticals Pharmaceuticals GLAND GLAND

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

  • Promoters 
    57.86%
    Public 
    42.14%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    57.86%
    Public 
    42.14%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    57.86%
    Public 
    42.14%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    57.86%
    Public 
    42.14%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    57.86%
    Public 
    42.14%
    Shares held by Employee Trusts 
    0.00%

Gland Pharma Limited FAQ's

What is the range of today's stock performance for Gland Pharma Limited?

Today's stock performance witnessed a fluctuation from a minimum of 1,781.05 on the NSE (National Stock Exchange) to a maximum of 1,838.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,787.70 to a high of 1,831.70.

What are the 52-week low and high values for Gland Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 1,585.70 (occurred on 23-Oct-2024) and a high of 2,220.95 (achieved on 06-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,590.00 (on 24-Oct-2024), and the 52-week high is 2,220.95 (on 06-Aug-2024).

What was the opening and previous closing prices for Gland Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 1,585.70 (occurred on 23-Oct-2024) and a high of 2,220.95 (achieved on 06-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,590.00 (on 24-Oct-2024), and the 52-week high is 2,220.95 (on 06-Aug-2024).

What is the total volume and traded value for Gland Pharma Limited for the day?

The total volume is 1, and the total traded value is 15.79 (₹ Lakhs).

What are the upper and lower circuit limits for Gland Pharma Limited?

The upper circuit limit is 2,175.90, and the lower circuit limit is 1,450.60.

What is the market cap and PE ratio for Gland Pharma Limited?

The market cap is ₹294.74 Cr, and the PE ratio (TTM) is 43.20.

What is the PB ratio, industry P/E, and debt to equity ratio for Gland Pharma Limited?

The PB ratio is 3.51, industry P/E is 43.20 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Gland Pharma Limited?

ROE is 12.02, EPS is 66.94, book value is 509.34

What are the revenue and profit figures for the latest quarter and previous quarters for Gland Pharma Limited?

In Sep 2023, Revenue is ₹10106670000.00, and Profit is ₹2575270000.00. In Jun 2023, Revenue is ₹8840700000.00, and Profit is ₹1875820000.00.

When was Gland Pharma Limited listed, and what industry does it belong to?

The company, Gland Pharma Limited, was listed in Nov 2020 and belongs to the Pharmaceuticals industry. Its NSE symbol is GLAND.

What is the current shareholding pattern of the Gland Pharma Limited?

As of latest available update, promoters hold 57.86%, the public holds 42.14%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
29
online
248
Threads
95
Settings
Back
Top